Article
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression
medRxiv · 2021 · Kong, T.; Laranjeira, A. B. A.; Yang, K.; Fisher, D.; Yu, L.; Wang, A. Z.; Ruzinova, M.; Fowles, J.; Allen, M.; Celik, H.; Challen, G.; Huang, S.; Oh, S.
Key facts
| Title | DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression |
|---|---|
| First author | Kong, T.; Laranjeira, A. B. A.; Yang, K.; Fisher, D.; Yu, L.; Wang, A. Z.; Ruzinova, M.; Fowles, J.; Allen, M.; Celik, H.; Challen, G.; Huang, S.; Oh, S. |
| Journal | medRxiv |
| Published | Jul 2, 2021 |
| DOI | 10.1101/2021.06.27.449656 |
| Devices mentioned | K041074, K232879, K242783, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 4 more |
| Product codes mentioned | GKZ, PSY, JCC, JJH, NJT, PFF, PFT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1